Skip to main content

Advertisement

SpringerLink
Log in

Outpatient benzodiazepine utilization in Croatia: drug use or misuse

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Benzodiazepines are commonly prescribed medications, especially among elderly, despite known risks and guidelines focused on short term usage. There is an increased trend of benzodiazepine consumption in Croatia. Consumption of anxiolytics in 2015 and 2016 in Croatia can almost entirely be ascribed to benzodiazepines, with diazepam being the most commonly prescribed drug, followed by alprazolam. Objective The aim of this study was to examine benzodiazepine utilization habits among the Croatian population. Setting This study was conducted on the national level, based on digital prescribing data. Method Data regarding the prescription of anxiolytics in Croatia was sourced and analyzed from the Croatian Health Insurance Fund database for the years 2015 and 2016. Drugs included in the study were classified according to The Anatomical and Therapeutic Classification of Medicines System, and consist of several chemical therapeutic subgroups (N05BA, N05BC, N05CD, N05CF). Main outcome measures The prescribing frequency of the most often prescribed benzodiazepines in Croatia. Results The total number of benzodiazepine prescriptions was 5,085,695 in 2015, and 5,294,075 in 2016; this represents a 208,380 increase in prescriptions, or 4.1% more than the previous year. The number of patients who utilized benzodiazepines showed an increase from 860,664 (8.67%) in 2015 to 876,046 (8.76%) in 2016. In relation to gender, benzodiazepine consumption was higher among female patients in all age groups, with the number of utilized benzodiazepine prescriptions per patient being highest in the oldest age group (80 +), comprising 7 prescriptions per patient in a 12 months period. Conclusion Increased utilization and long-term treatment with benzodiazepines remains a serious challenge for the health care system in Croatia. National prescription guidelines, improved control of benzodiazepine usage and prescriptions, along with restricted release drug lists, should all be considered as potential measures to rationalize benzodiazepine prescription, control unnecessary expenditure in the country and improve the well-being of the patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Source: Organisation for Economic Co-operation and Development (OECD), available at: https://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT# and The Agency for Medicinal Products and Medical Devices (HALMED, Croatia), available at: http://halmed.hr/fdsak3jnFsk1Kfa/ostale_stranice/Tablica_16-Ukupna_potrosnja_lijekova_u_2016_godini.pdf and http://halmed.hr/fdsak3jnFsk1Kfa/ostale_stranice/Tablica_16-Ukupna_potrosnja_lijekova_u_2015_godini.pdf

Similar content being viewed by others

References

  1. World Health Organization. Mental health action plan 2013–2020. Geneva, Switzerland. 2013. https://apps.who.int/iris/bitstream/handle/10665/89966/9789241506021_eng.pdf?sequence=1. Accessed 6 Aug 2018.

  2. OECD/EU. Health at a Glance: Europe: State of Health in the EU Cycle, OECD Publishing, Paris, 2018. doi: 10.1787/health_glance_eur-2018-en.

  3. Eurostat. Mental health and related issues statistics. https://ec.europa.eu/eurostat/statistics-explained/index.php/Mental_health_and_related_issues_statistics. Accessed 14 Feb 2019.

  4. Spanemberg L, Nogueira EL, da Silva CT, Dargél AA, Menezes FS, Cataldo Neto A. High prevalence and prescription of benzodiazepines for elderly: data from psychiatric consultation to patients from an emergency room of a general hospital. Gen Hosp Psychiatr. 2011;33:45–50.

    Article  Google Scholar 

  5. Llorente MD, David D, Golden AG, Silverman MA. Defining patterns of benzodiazepine use in older adults. J Geriatr Psychiatr Neurol. 2000;13:150–60.

    Article  CAS  Google Scholar 

  6. Noto AR, Carlini EA, Mastroianni PC, Alves VC, Galduroz JC, Kuroiwa W, et al. Analysis of prescription and dispensation of psychotropic medications in two cities in the State of São Paulo, Brazil. Braz J Psychiatr. 2002;24:68–73.

    Article  Google Scholar 

  7. Rodrigues MA, Facchini LA, Lima MS. Modificações nos padrões de consumo de psicofármacos em localidade do Sul do Brasil. Rev Saude Publica. 2006;40:107–14.

    Article  PubMed  Google Scholar 

  8. Živković K, Zelić A, Štimac D, Ožić S, Živković N. A study on the quality of outpatient prescription of psychopharmaceuticals in the City of Zagreb 2006–2009. Coll Antropol. 2014;38:717–24.

    PubMed  Google Scholar 

  9. García MAF, de Labry Lima AO, Ferrer Lopez I, Bermúdez-Tamayo C. Analysis of changes in trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs. J Pharm Policy Pract. 2018;11:1.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hardeland R. New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists. Neuropsychiatr Dis Treat. 2009;5:341–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Bourgeois J, Elseviers MM, Azermai M, van Bortel L, Petrovic M, Vander Stichele RR. Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages. Eur J Clin Pharmacol. 2012;68:833–44.

    Article  CAS  PubMed  Google Scholar 

  12. Donoghue J, Lader M. Usage of benzodiazepines: a review. Int J Psychiatry Clin Pract. 2010;14:78–877.

    Article  CAS  PubMed  Google Scholar 

  13. Kurko TA, Saastamoinen LK, Tahkapaa S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, et al. Longterm use of benzodiazepines: definitions, prevalence and usage patterns—a systematic review of register-based studies. Eur Psychiatry. 2015;30:1037–47.

    Article  CAS  PubMed  Google Scholar 

  14. Benzodiazepine Committee. Benzodiazepines: good practice guidelines for clinicians. Dublin: Department of Health and Children. 2002. https://health.gov.ie/wp-content/uploads/2014/04/Benzodiazepines-Good-Practice-Guidelines.pdf. Accessed 12 Aug 2018.

  15. Barker MJ, Greenwood KM, Jackson M, Crowe SF. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol. 2004;18:37–48.

    CAS  Google Scholar 

  16. Cumming RG, Le Conteur DG. Benzodiazepines and risk of hip fractures in older people. CNS Drugs. 2003;17:825–37.

    Article  CAS  PubMed  Google Scholar 

  17. Lader M. Benzodiazepines revisited—will we ever learn? Addiction. 2011;106:2086–109.

    Article  PubMed  Google Scholar 

  18. De Gage SB, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, et al. Benzodiazepine use and risk of Alzheimer’s disease: case-control study. BMJ. 2014;349:g5205.

    Article  CAS  Google Scholar 

  19. Yaffe K, Boustani M. Benzodiazepines and risk of Alzheimer’s disease. BMJ. 2014;349:g5312.

    Article  PubMed  CAS  Google Scholar 

  20. Siriwardena AN, Qureshi MZ, Dyas JV, Middleton H, Orner R. Magic bullets for insomnia? Patients’ use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. Br J Gen Pract. 2008;58:417–22.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Peritogiannis V, Manthopoulou T, Mavreas V. Long-term benzodiazepine treatment in patients with psychotic disorders attending a mental health service in rural Greece. J Neurosci Rural Pract. 2016;7:S26–S30.

    PubMed  PubMed Central  Google Scholar 

  22. Johnell K, Fastbom J. The use of benzodiazpines and related drugs amongst older people in Sweden: associated factors and concomitant use of other psychotropics. Int J Geriatr Psychiatr. 2009;24:731–8.

    Article  Google Scholar 

  23. Hoffmann F, Hies M, Glaeske G. Regional variations of private prescriptions for the non-benzodiazepine hypnotics zolpidem and zopiclone in Germany. Pharmacoepidemiol Drug Saf. 2010;19:1071–7.

    Article  PubMed  Google Scholar 

  24. Weymann D, Gladstone EJ, Smolina K, Morgan SG. Longterm sedative use among community-dwelling adults: a population-based analysis. CMAJ Open. 2017;5:E52–E60.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs. 2009;23:19–34.

    Article  CAS  PubMed  Google Scholar 

  26. Ostini R, Jackson C, Hegney D, Tett SE. How is medication prescribing ceased? A systematic review. Med Care. 2011;49:24–36.

    Article  PubMed  Google Scholar 

  27. Cloos J, Ferreira V. Current use of benzodiazepines in anxiety disorders. Curr Opin Psychiatr. 2009;22:90–5.

    Article  Google Scholar 

  28. Voshaar RC, Couvee JE, van Balkom AJ, Mulder PG, Zitman FG. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatr. 2006;189:213–20.

    Article  Google Scholar 

  29. Ashton H. Guidelines for the rational use of benzodiazepines—when and what to use. Drugs. 1994;48:25–40.

    Article  CAS  PubMed  Google Scholar 

  30. Canadian Agency for Drugs and Technologies in Health. Benzodiazepines in older adults: a review of clinical effectiveness, cost-effectiveness, and guidelines. 2010. https://www.cadth.ca/media/pdf:M0022_Benzodiazepines_Elderly.pdf. Accessed 3 Feb 2019.

  31. National Institute for Health and Clinical Excellence. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. 2011. https://www.nice.org.uk/nicemedia/live/13314/52599/52599.pdf. Accessed 12 Aug 2018.

  32. Martin JL, Sainz-Pardo M, Furukawa TA, Martin-Sanchez E, Seoane T, Galan C. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J Psychopharmacol. 2007;21(7):774–82.

    Article  CAS  PubMed  Google Scholar 

  33. Béland SG, Préville M, Dubois MF, Lorrain D, Voyer P, Bossé C, et al. Scientific committee of the ESA study: the association between length of benzodiazepine use and sleep quality in older population. Int J Geriatr Psychiatr. 2011;26:908–15.

    Article  Google Scholar 

  34. Polić-Vižintin M, Štimac D, Šostar Z, Tripković I. Distribution and trends in outpatient utilization of generic versus brand name psychopharmaceuticals during a ten-year period in Croatia. BMC Health Serv Res. 2014;14:343.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Ministry of Health. Pravilnik o mjerilima za razvrstavanje lijekova te o propisivanju i izdavanju lijekova na recept, Zagreb, NN 86/2013. 90/2013. https://narodne-novine.nn.hr/clanci/sluzbeni/2013_07_86_1937.html. Accessed 12 Aug 2018.

  36. Hrvatski zavod za zdravstveno osiguranje. Arhiva liste Lijekova. https://www.hzzo.hr/zdravstveni-sustav-rh/trazilica-za-lijekove-s-vazecih-lista/arhiva-liste-lijekova/. Accessed 28 Jun 2019.

  37. Jakovljević M, Lacković Z. Benzodiazepini u suvremenoj medicini. 1st ed. Zagreb: Medicinska naklada; 2001.

    Google Scholar 

  38. Francetić I. Farmakoterapijski priručnik. Zagreb: Medicinska naklada; 2015.

    Google Scholar 

  39. Francetić I, Vitezić D. Klinička farmakologija. 2nd ed. Zagreb: Medicinska naklada; 2014.

    Google Scholar 

  40. WHO Collaborating Centre for Drug Statistics methodology. https://www.whocc.no/atc_ddd_index/. Accessed 10 Sep 2018.

  41. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision. https://apps.who.int/classifications/icd10/browse/2016/en. Accessed 11 Sep 2018.

  42. Rouby F, Pradel V, Frauger E, Pauly V, Natali F, Reggio P, et al. Assessment of abuse of tianeptine from a reimbursement database using 'doctor-shopping' as an indicator. Fundam Clin Pharmacol. 2012;26:286–94.

    Article  CAS  PubMed  Google Scholar 

  43. Croatian Bureau of Statistics. Census of Population, Households and Dwellings in the Republic of Croatia in 2011. https://www.dzs.hr. Accessed 11 Sep 2018.

  44. Croatian Bureau of Statistics. 48th Statistical Yearbook of the Republic of Croatia. 2016. https://www.dzs.hr/. Accessed 11 Sep 2018.

  45. Vojvodić Ž, Nelken-Bestvina D, Kurc- Bionda A, Štimac D. Trends in prescribing in primary care in Croatia, 2000–2012: prescribing volume, costs and regulatory measures. Coll Antropol. 2014;38(S2):67–72.

    PubMed  Google Scholar 

  46. IMS Institute for Healthcare Informatics. Global Use of Medicines in 2020. Outlook and Implications. 2015. https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/global-medicines-use-in-2020. Accessed 14 Feb 2019.

  47. Agencija za lijekove i medicinske proizvode—HALMED. Potrošnja lijekova u Hrvatskoj 2012–2016. https://www.halmed.hr/fdsak3jnFsk1Kfa/publikacije/Potrosnja-lijekova-u-RH_2012-2016.pdf. Accessed 15 Oct 2018.

  48. Lyons JS, Larson DB, Hromco J. Clinical and economic evaluation of benzodiazepines: a value analysis. Pharmacoeconomics. 1992;2:397–407.

    Article  CAS  PubMed  Google Scholar 

  49. United Nations. Psychotropic Substances 2018—Statistics for 2017. https://www.incb.org/documents/Psychotropics/technical-publications/2018/PSY_Technical_Publication_2018.pdf. Accessed 26 Mar 2019.

  50. Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol. 2017;73:927–35.

    Article  CAS  PubMed  Google Scholar 

  51. World Health Organization. Mental health-data and resources https://www.euro.who.int/en/health-topics/noncommunicable-diseases/mental-health/data-and-resources. Accessed 31 Jan 2019.

  52. Organisation for Economic Co-operation and Development. OECD/EU database. 2018. https://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT. Accessed 31 Jan 2019.

  53. Urzal J, Pedro AB, Oliveira IF, Romero I, Achega M, Correia I, et al. Inappropriate prescribing to elderly patients in an internal medicine ward. Acta Med Port. 2019;32:141–8.

    Article  PubMed  Google Scholar 

  54. Sánchez V, Pilar M, Macías Saint-Gerons D, Cdela FH, González Bermejo D, Montero Corominas D et al. Evolución del uso de medicamentos ansiolíticos e hipnóticos en España durante el período 2000–2011. Revista Española de Salud Pública. 2013;87:247–55.

    Article  Google Scholar 

  55. The Agency for Medicinal Products and Medical Devices (Croatia). Ukupna potrošnja lijekova u 2016. Godini. https://halmed.hr/fdsak3jnFsk1Kfa/ostale_stranice/Tablica_16-Ukupna_potrosnja_lijekova_u_2016_godini.pdf. Accessed 31 Jan 2019.

  56. The Agency for Medicinal Products and Medical Devices (Croatia). Ukupna potrošnja lijekova u 2015. Godini. https://halmed.hr/fdsak3jnFsk1Kfa/ostale_stranice/Tablica_16-Ukupna_potrosnja_lijekova_u_2015_godini.pdf. Accessed 31 Jan 2019.

  57. Bénard-Laribière A, Noize P, Pambrun E, Bazin F, Verdoux H, Tournier M, et al. Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine users. Eur J Clin Pharmacol. 2016;72:869–76.

    Article  PubMed  CAS  Google Scholar 

  58. Barbui C. Drug epidemiology in Italy: methods and ethical issues: The example of psychiatry. Pharmacoepidemiol Drug Saf. 2001;10:647–52.

    Article  CAS  PubMed  Google Scholar 

  59. van Eijk JTM, Bosma H, Jonkers CCM, Lamers F, Muijrers PEM. Prescribing Antidepressants and benzodiazepines in the Netherlands: is chronic physical illness involved? Depress Res Treat. 2010. https://doi.org/10.1155/2010/105931.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Kapil V, Green JL, Le Lait C, Wood DM, Dargan PI. Misuse of benzodiazepines and Z-drugs in the UK. Br J Psychiatr. 2014;205:407–8.

    Article  CAS  Google Scholar 

  61. Naqvi H, Sabzwari S, Hussain S, Islam M, Zaman M. General practitioners' awareness and management of common psychiatric disorders: a community-based survey from Karachi. Pak East Mediterr Health J. 2012;18:446–53.

    Article  CAS  Google Scholar 

  62. Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc. 2003;51:671–7.

    Article  PubMed  Google Scholar 

  63. Voyer P, Préville M, Cohen D, Berbiche D, Béland SG. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can J Aging. 2010;29:205–13.

    Article  PubMed  Google Scholar 

  64. Sonnenberg CM, Bierman EJ, Deeg DJ, Comijs HC, van Tilburg W, Beekman AT. Ten-year trends in benzodiazepine use in the Dutch population. Soc Psychiatr Psychiatr Epidemiol. 2012;47:293–301.

    Article  Google Scholar 

  65. Kurko T, Saastamoinen LK, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen M, et al. Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014. Pharmacoepidemiol Drug Saf. 2018;27:674–82.

    Article  CAS  PubMed  Google Scholar 

  66. Vlastelica M, Jelaska M. Zašto su benzodiazepini još uvijek u širokoj primjeni? Acta Med Croatica. 2012;66:137–40.

    PubMed  Google Scholar 

  67. Innovative Pharmaceutical Initiative: Drug policy in Croatia. Attitudes toward drug expenditure rationalization. 2013. https://ifi.hr/wp-content/uploads/2017/09/carpc-ifi-drug-policy-in-croatia.pdf. Accessed 12 Sep 2018.

  68. Brett J, Murnion B. Management of benzodiazepine misuse and dependence. Aust Prescr. 2015;38(5):152–5.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Millar A, Hughes C, Ryan C. Evaluating the prevalence of potentially inappropriate prescribing in older adults in intermediate care facilities: a cross-sectional observational study. Int J Clin Pharm. 2017;39:527–35.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Marriott S, Tyrer P. Benzodiazepine dependence: Avoidance and withdrawal. Drug Saf. 1993;9:93–103.

    Article  CAS  PubMed  Google Scholar 

  71. Siriwardena AN, Qureshi Z, Gibson S, Collier S, Latham M. GPs’ attitudes to benzodiazepine and “Z-drug” prescribing: a barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract. 2006;56:964–7.

    PubMed  PubMed Central  Google Scholar 

  72. Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Cimolai N. Zopiclone: is it a pharmacologic agent for abuse? Can Fam Physician. 2007;53:2124–9.

    PubMed  PubMed Central  Google Scholar 

  74. Popović B, Quadranti NR, Matanović SM, Lisica ID, Ljubotina A, Duliba DP, et al. Potentially inappropriate prescribing in elderly outpatients in Croatia. Eur J Clin Pharmacol. 2014;70:737–44.

    Article  PubMed  Google Scholar 

  75. Tournier M, Pariente A, Bégaud B, Bénard-Laribière A. Use and misuse of benzodiazepines out of France. Presse Med. 2018;47:882–5.

    Article  CAS  PubMed  Google Scholar 

  76. Čulig J, Leppee M, Štimac D, Kuvačić I, Pulanić-Klepac T, Herman R, et al. Presječno istraživanje uporabe lijekova u trudnoći. Lijec Vjesn. 2007;129:253–9.

    PubMed  Google Scholar 

  77. Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13:214–23.

    PubMed  PubMed Central  Google Scholar 

  78. Vlahović-Palcevski V, Bergman U. Quality of prescribing for the elderly in Croatia-computerized pharmacy data can be used to screen for potentially inappropriate prescribing. Eur J Clin Pharmacol. 2004;60:217–20.

    Article  PubMed  Google Scholar 

  79. Divac N, Jasović M, Djukić L, Vujnović M, Babić D, Bajcetić M, et al. Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia. Pharmacoepidemiol Drug Saf. 2004;13:315–22.

    Article  CAS  PubMed  Google Scholar 

  80. Petrushevska T, Stefanovska VV. Use of Medicines from the Group of Benzodiazepines in the Period of 2003–2013 Year in the Republic of Macedonia. Open Access Maced J Med Sci. 2015;3:151–7.

    PubMed  Google Scholar 

  81. Sidorchuk A, Isomura K, Molero Y, Hellner C, Lichtenstein P, Chang Z, et al. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study. PLoS Med. 2018;15:e1002635.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Ndukwe HC, Tordoff JM, Wang T, Nishtala PS. Psychotropic medicine utilization in older people in New Zealand from 2005 to 2013. Drugs Aging. 2014;31:755–68.

    Article  PubMed  Google Scholar 

  83. Rapić M, Cikač T, Barišić-Marčac Z, Štimac D. Trends in psychotropic drug utilization in Croatia. Coll Antropol. 2014;38:S37–S42.

    Google Scholar 

  84. Štimac D, Vukušić I, Čulig J, Šostar Z. Comparison of outpatient utilization of psychopharmaceuticals between Croatia and Scandinavian countries (2001–2003). Medicinski Glasnik. 2007;4:14–20.

    Google Scholar 

  85. Balon R, Chouinard G, Cosci F, Dubovsky SL, Fava GA, Freire RC, et al. International task force on benzodiazepines. Psychother Psychosom. 2018;87:193–4.

    Article  PubMed  Google Scholar 

  86. Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, et al. Benzodiazepines: risks and benefits. A reconsideration. J Psychopharmacol. 2013;27:967–71.

    Article  CAS  PubMed  Google Scholar 

  87. Paulozzi LJ, Mack KA, Hockenberry JM. Variation among states in prescribing of opioid pain relievers and benzodiazepines–United States, 2012. J Safety Res. 2014;51:125–9.

    Article  PubMed  Google Scholar 

  88. Potočnjak I, Likić R, Degoricija V, Nham E, Wettermark B. The benzodiazepine nation of Croatia: an observational, comparative study of psychotropic drug utilization between Croatia and Sweden 2014–2015. Expert Rev Pharmacoecon Outcomes Res. 2018;18:641–6.

    Article  PubMed  Google Scholar 

  89. Johnson CF, Frei C, Downes N, McTaggart SA, Akram G. Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study. Br J Gen Pract. 2016;66:e410–e415415.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, van de Lisdonk EH, Breteler MH, et al. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. Br J Psychiatr. 2003;182:498–504.

    Article  Google Scholar 

Download references

Acknowledgements

Authors would like to thank Croatian Health Insurance Fund for providing the data analyzed in this article.

Author information

Authors and Affiliations

  1. Sestre Milosrdnice University Hospital Center, Vinogradska cesta 29, Zagreb, Croatia

    Marija Delaš Aždajić, Stjepan Aždajić & Mirna Šitum

  2. School of Medicine, University of Zagreb, Šalata 3, Zagreb, Croatia

    Robert Likić & Danijela Štimac Grbić

  3. Clinical Hospital Centre Zagreb, Kišpatićeva ul. 12, Zagreb, Croatia

    Robert Likić

  4. School of Dental Medicine, University of Zagreb, Ivana Gundulića 5, Zagreb, Croatia

    Mirna Šitum

  5. Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Trg Svetog Trojstva 3, Osijek, Croatia

    Ivana Lovrić

  6. Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, Crkvena 21, Osijek, Croatia

    Ivana Lovrić

  7. Croatian Institute of Public Health, Rockefellerova ulica 12, Zagreb, Croatia

    Danijela Štimac Grbić

Authors
  1. Marija Delaš Aždajić
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Likić
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stjepan Aždajić
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mirna Šitum
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ivana Lovrić
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Danijela Štimac Grbić
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marija Delaš Aždajić.

Ethics declarations

Funding

The authors received no funding for this work.

Conflicts of interest

All authors declare that they have no conflict of interest regarding the work presented in the manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Delaš Aždajić, M., Likić, R., Aždajić, S. et al. Outpatient benzodiazepine utilization in Croatia: drug use or misuse. Int J Clin Pharm 41, 1526–1535 (2019). https://doi.org/10.1007/s11096-019-00915-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-019-00915-2

Keywords

Search

Navigation